Increased rate of asporogenous mutations following treatment of Bacillus subtilis spores with ethyl methanesulfonate.
D000596:Amino Acids; D001412:Bacillus subtilis / Q000187:drug effects*; D001435:Bacteriophages; D002021:Buffers; D002470:Cell Survival; D004352:Drug Resistance, Microbial; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation; D010447:Peptide Hydrolases; D010641:Phenotype; D010710:Phosphates / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011687:Purines; D011743:Pyrimidines; D013170:Spores / Q000187:drug effects*; D013171:Spores, Bacterial / Q000187:drug effects; D013451:Sulfonic Acids / Q000494:pharmacology*; D013696:Temperature
D000596:Amino Acids; D002021:Buffers; D009153:Mutagens; D010710:Phosphates; D011687:Purines; D011743:Pyrimidines; D013451:Sulfonic Acids; D010447:Peptide Hydrolases; D011188:Potassium